We are live on ! Find out more
PTC

Provident Trust Company Portfolio holdings

AUM $4.77B
1-Year Est. Return 29.31%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+29.31%
3 Year Est. Return
+84.13%
5 Year Est. Return
+85.04%
10 Year Est. Return
+502.53%
AUM
$4.88B
AUM Growth
+$549M
Cap. Flow
+$34.8M
Cap. Flow %
0.71%
Top 10 Hldgs %
80.31%
Holding
27
New
Increased
6
Reduced
11
Closed

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$46.6M
2
TSCO icon
Tractor Supply
TSCO
+$41.8M
3
FISV
Fiserv Inc
FISV
+$37.5M
4
TJX icon
TJX Companies
TJX
+$23.7M
5
LUV icon
Southwest Airlines
LUV
+$12M

Sector Composition

Rank Sector Weight
1 Financials 25.56%
2 Communication Services 22.26%
3 Technology 13.71%
4 Consumer Staples 11.02%
5 Consumer Discretionary 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$342B
$410K 0.01%
2,800
JNJ icon
27
Johnson & Johnson
JNJ
$608B
$393K 0.01%
2,509
-132
-5% -$20.2K

Similar funds

Provident Trust Company's Q4 2023 Portfolio in Review

As of Q4 2023, Provident Trust Company held 27 positions worth $4.88B, up 13% from $4.33B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. Provident Trust Company opened no new positions and made no exits, leaving the 27-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Communication Services and Technology.

  • Provident Trust Company added most to GSK in Q4 2023, an estimated $46.6M increase.
  • Provident Trust Company's biggest Q4 2023 reduction was Charles Schwab, cutting an estimated $85.1M.
  • Provident Trust Company's ten largest holdings make up 80% of its $4.88B portfolio in Q4 2023.
  • Provident Trust Company opened 0 new positions and closed 0 in Q4 2023.
  • Provident Trust Company's portfolio value rose 13% quarter-over-quarter to $4.88B.

Based on Provident Trust Company's 13F filing for Q4 2023, filed 5 Feb 2024.